Home › Viral Infections › Maryland › Baltimore
Viral Infections clinical trials in Baltimore, MD
5 studies for Viral Infections are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Johns Hopkins Hospital, Baltimore
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
RecruitingPhase 2
- University of Maryland, Baltimore
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Annapolis · 22 mi away
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
RecruitingPhase 1/2
- Johns Hopkins, Baltimore
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
RecruitingPhase 1
- Johns Hopkins University, Baltimore
About Viral Infections
Viruses cause familiar infections such as the common cold, but they also cause severe illnesses. Learn more about viral infections and their symptoms.
More about Viral Infections on MedlinePlus
Viral Infections trials in other cities
- Washington, DC12 studies
- Boston, MA6 studies
- Houston, TX6 studies
- Hialeah, FL5 studies
- Cincinnati, OH4 studies
- Columbus, OH4 studies
- Dallas, TX4 studies
- Atlanta, GA4 studies
- Los Angeles, CA3 studies
- San Francisco, CA3 studies
- St. Louis, MO3 studies
- Omaha, NE3 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Bladder Cancer24 studies
- Heart Failure24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.